ClinicalTrials.Veeva

Menu

Retrospective Study in the Use of the Alfapump and the Treatment of Malignant Ascites

S

Sequana Medical

Status

Completed

Conditions

Malignant Ascites

Treatments

Device: Alfapump

Study type

Observational

Funder types

Industry

Identifiers

NCT03200106
2017-AAR-011

Details and patient eligibility

About

Treatment of malignant ascites with the alfapump offers a new treatment option for this patient group. So far, there is no systematic analysis of patients with this indication available in the literature.

This retrospective analysis offers the possibility to assemble already existing data within a reasonably short time frame. Based on this analysis, a prospective analysis can be designed.

Enrollment

17 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with malignant ascites
  • Patients with alfapump implanted for malignant ascites
  • Patients 18 years or older at the time of death

Exclusion criteria

  • Patient is alive at the time of inclusion assessment

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems